Abbott Laboratories (ABT) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $109.74 +1.03%
Financial Fact:
Selling, general and administrative: 1.63B
Today's EPS Names:
ECX, ONON, LODE, More
Financial Fact:
Selling, general and administrative: 1.63B
Today's EPS Names:
ECX, ONON, LODE, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q4 EPS of $1.51, $0.01 better than the analyst estimate of $1.50. Revenue for the quarter came in at $10.8 billion versus the consensus estimate of $10.58 billion.
Abbott Laboratories sees FY2013 ongoing EPS of $1.98-2.04, which the company called "strong."
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Abbott Laboratories sees FY2013 ongoing EPS of $1.98-2.04, which the company called "strong."
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synthesis Energy Systems (SES) Reports In-Line Q2 EPS, Misses on Revenue; Offers FY26 Revenue Guidance
- Vinci Partners Investments Ltd. (VINP) Misses Q2 EPS by 22c
- William Blair Downgrades On Holding AG (ONON) to Market Perform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
